Islam Saqib's most recent trade in SpringWorks Therapeutics Inc was a trade of 954,869 Common Stock done . Disclosure was reported to the exchange on July 1, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| SpringWorks Therapeutics Inc | Islam Saqib | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Jul 2025 | 954,869 | 0 (0%) | 2% | - | Common Stock | |
| SpringWorks Therapeutics Inc | Islam Saqib | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Jul 2025 | 769,804 | 0 | - | - | Stock Option (Right to Buy) | |
| SpringWorks Therapeutics Inc | Islam Saqib | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Jul 2025 | 579,749 | 0 | - | - | Performance Share Units | |
| SpringWorks Therapeutics Inc | Saqib Islam | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Jul 2025 | 325,000 | 0 | - | - | Stock Option (Right to Buy) | |
| SpringWorks Therapeutics Inc | Islam Saqib | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Jul 2025 | 260,000 | 0 | - | - | Stock Option (Right to Buy) | |
| SpringWorks Therapeutics Inc | Saqib Islam | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Jul 2025 | 250,000 | 0 | - | - | Stock Option (Right to Buy) | |
| SpringWorks Therapeutics Inc | Saqib Islam | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Jul 2025 | 176,411 | 0 | - | - | Stock Option (Right to Buy) | |
| SpringWorks Therapeutics Inc | Saqib Islam | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Jul 2025 | 109,329 | 0 | - | - | Stock Option (Right to Buy) | |
| SpringWorks Therapeutics Inc | Saqib Islam | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Jul 2025 | 22,760 | 0 | - | - | Stock Option (Right to Buy) | |
| ARS Pharmaceuticals Inc | Saqib Islam | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2025 | 30,000 | 30,000 | - | - | Stock Option (right to buy) | |
| Passage Bio Inc | Saqib Islam | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2025 | 201,857 | 201,857 | - | - | Director Stock Option (right to buy) | |
| SpringWorks Therapeutics Inc | Saqib Islam | Director, Chief Executive Officer | 27 Feb 2025 | 30,756 | 1,003,869 (2%) | 0% | 53.4 | 1,642,678 | Common Stock | |
| SpringWorks Therapeutics Inc | Saqib Islam | Director, Chief Executive Officer | 27 Feb 2025 | 23,600 | 968,469 (2%) | 0% | 54.2 | 1,280,135 | Common Stock | |
| SpringWorks Therapeutics Inc | Saqib Islam | Director, Chief Executive Officer | 27 Feb 2025 | 11,800 | 992,069 (2%) | 0% | 53.0 | 625,017 | Common Stock | |
| SpringWorks Therapeutics Inc | Saqib Islam | Director, Chief Executive Officer | 27 Feb 2025 | 11,600 | 956,869 (2%) | 0% | 55.2 | 639,783 | Common Stock | |
| SpringWorks Therapeutics Inc | Saqib Islam | Director, Chief Executive Officer | 27 Feb 2025 | 1,400 | 955,469 (2%) | 0% | 56.1 | 78,588 | Common Stock | |
| SpringWorks Therapeutics Inc | Saqib Islam | Director, Chief Executive Officer | 27 Feb 2025 | 600 | 954,869 (2%) | 0% | 56.9 | 34,134 | Common Stock | |
| SpringWorks Therapeutics Inc | Saqib Islam | Director, Chief Executive Officer | 20 Feb 2025 | 24,260 | 1,039,693 (2%) | 0% | 60.1 | 1,458,053 | Common Stock | |
| SpringWorks Therapeutics Inc | Saqib Islam | Director, Chief Executive Officer | 20 Feb 2025 | 5,068 | 1,034,625 (2%) | 0% | 61.2 | 310,348 | Common Stock | |
| SpringWorks Therapeutics Inc | Saqib Islam | Director, Chief Executive Officer | 14 Feb 2025 | 10,672 | 1,063,953 (2%) | 0% | 59.9 | 639,490 | Common Stock | |
| SpringWorks Therapeutics Inc | Saqib Islam | Director, Chief Executive Officer | 12 Feb 2025 | 85,309 | 1,087,811 (2%) | 0% | 0 | Common Stock | ||
| SpringWorks Therapeutics Inc | Saqib Islam | Director, Chief Executive Officer | 12 Feb 2025 | 13,186 | 1,074,625 (2%) | 0% | 59.3 | 781,666 | Common Stock | |
| SpringWorks Therapeutics Inc | Saqib Islam | Director, Chief Executive Officer | 10 Feb 2025 | 48,000 | 1,002,502 (2%) | 0% | 53.3 | 2,558,237 | Common Stock | |
| SpringWorks Therapeutics Inc | Saqib Islam | Director, Chief Executive Officer | 10 Jan 2025 | 109,329 | 109,329 | - | - | Stock Option (Right to Buy) | ||
| SpringWorks Therapeutics Inc | Saqib Islam | Director, Chief Executive Officer | 10 Jan 2025 | 74,834 | 1,050,502 (2%) | 0% | 0 | Common Stock | ||
| SpringWorks Therapeutics Inc | Saqib Islam | Director, Chief Executive Officer | 04 Jan 2025 | 13,469 | 1,000,899 (2%) | 0% | 38.2 | 514,381 | Common Stock | |
| SpringWorks Therapeutics Inc | Saqib Islam | Director, Chief Executive Officer | 04 Jan 2025 | 12,872 | 988,027 (2%) | 0% | 38.2 | 491,582 | Common Stock | |
| SpringWorks Therapeutics Inc | Saqib Islam | Director, Chief Executive Officer | 04 Jan 2025 | 12,359 | 975,668 (2%) | 0% | 38.9 | 480,271 | Common Stock | |
| SpringWorks Therapeutics Inc | Saqib Islam | Director, Chief Executive Officer | 02 Dec 2024 | 45,011 | 1,018,357 (2%) | 0% | 41.3 | 1,860,422 | Common Stock | |
| SpringWorks Therapeutics Inc | Saqib Islam | Director, Chief Executive Officer | 02 Dec 2024 | 3,989 | 1,014,368 (2%) | 0% | 41.8 | 166,936 | Common Stock | |
| SpringWorks Therapeutics Inc | Saqib Islam | Director, Chief Executive Officer | 03 Sep 2024 | 32,400 | 1,079,968 (2%) | 0% | 40.1 | 1,299,224 | Common Stock | |
| SpringWorks Therapeutics Inc | Saqib Islam | Director, Chief Executive Officer | 03 Sep 2024 | 9,908 | 1,070,060 (2%) | 0% | 41.1 | 407,259 | Common Stock | |
| SpringWorks Therapeutics Inc | Saqib Islam | Director, Chief Executive Officer | 03 Sep 2024 | 6,692 | 1,063,368 (2%) | 0% | 42.1 | 281,550 | Common Stock | |
| ARS Pharmaceuticals Inc | Saqib Islam | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 40,000 | 40,000 | - | - | Stock Option (right to buy) | |
| SpringWorks Therapeutics Inc | Saqib Islam | Director, Chief Executive Officer | 03 Jun 2024 | 33,240 | 1,128,128 (2%) | 0% | 39.4 | 1,309,666 | Common Stock | |
| SpringWorks Therapeutics Inc | Saqib Islam | Director, Chief Executive Officer | 03 Jun 2024 | 8,760 | 1,119,368 (2%) | 0% | 40.6 | 355,363 | Common Stock | |
| SpringWorks Therapeutics Inc | Saqib Islam | Director, Chief Executive Officer | 03 Jun 2024 | 6,600 | 1,112,768 (2%) | 0% | 41.4 | 273,247 | Common Stock | |
| SpringWorks Therapeutics Inc | Saqib Islam | Director, Chief Executive Officer | 03 Jun 2024 | 400 | 1,112,368 (2%) | 0% | 42.1 | 16,837 | Common Stock | |
| Passage Bio Inc | Saqib Islam | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 47,693 | 47,693 | - | - | Director Stock Option (right to buy) | |
| SpringWorks Therapeutics Inc | Islam Saqib | Director, Chief Executive Officer | 04 Jan 2024 | 250,000 | 250,000 | - | - | Stock Option (Right to Buy) | ||
| SpringWorks Therapeutics Inc | Islam Saqib | Director, Chief Executive Officer | 04 Jan 2024 | 88,000 | 287,053 (0%) | 0% | 0 | Common Stock | ||
| SpringWorks Therapeutics Inc | Saqib Islam | Director, Chief Executive Officer | 04 Jan 2024 | 17,904 | 256,264 (0%) | 0% | 41.5 | 743,553 | Common Stock | |
| SpringWorks Therapeutics Inc | Islam Saqib | Director, Chief Executive Officer | 04 Jan 2024 | 12,885 | 274,168 (0%) | 0% | 38.0 | 489,115 | Common Stock | |
| ARS Pharmaceuticals Inc | Saqib Islam | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2023 | 40,000 | 40,000 | - | - | Stock Option (right to buy) | |
| Passage Bio Inc | Saqib Islam | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2023 | 24,000 | 24,000 | - | - | Director Stock Option (Right to Buy) | |
| SpringWorks Therapeutics Inc | Saqib Islam | Director, Chief Executive Officer | 07 Jan 2023 | 4,097 | 905,104 (2%) | 0% | 26.4 | 108,202 | Common Stock | |
| SpringWorks Therapeutics Inc | Saqib Islam | Director, Chief Executive Officer | 05 Jan 2023 | 260,000 | 260,000 | - | - | Stock Option (Right to Buy) | ||
| SpringWorks Therapeutics Inc | Saqib Islam | Director, Chief Executive Officer | 05 Jan 2023 | 84,175 | 917,601 (2%) | 0% | - | Common Stock | ||
| SpringWorks Therapeutics Inc | Saqib Islam | Director, Chief Executive Officer | 05 Jan 2023 | 8,400 | 909,201 (2%) | 0% | 27.5 | 231,168 | Common Stock | |
| Passage Bio Inc | Saqib Islam | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2022 | 24,000 | 24,000 | - | - | Director Stock Option (Right to Buy) | |
| SpringWorks Therapeutics Inc | Saqib Islam | Director, Chief Executive Officer | 07 Jan 2022 | 3,996 | 853,592 (1%) | 0% | 56.1 | 224,016 | Common Stock | |
| SpringWorks Therapeutics Inc | Saqib Islam | Director, Chief Executive Officer | 06 Jan 2022 | 244,258 | 244,258 | - | - | Stock Option (Right to Buy) | ||
| SpringWorks Therapeutics Inc | Saqib Islam | Director, Chief Executive Officer | 06 Jan 2022 | 78,370 | 857,588 (1%) | 0% | - | Common Stock | ||
| SpringWorks Therapeutics Inc | Saqib Islam | Director, Chief Executive Officer | 20 Oct 2021 | 10,083 | 779,218 (1%) | 0% | 58.7 | 591,527 | Common Stock | |
| SpringWorks Therapeutics Inc | Saqib Islam | Director, Chief Executive Officer | 18 Oct 2021 | 38,340 | 783,212 (1%) | 0% | 58.6 | 2,246,505 | Common Stock | |
| SpringWorks Therapeutics Inc | Saqib Islam | Director, Chief Executive Officer | 18 Oct 2021 | 14,077 | 769,135 (1%) | 0% | 58.8 | 827,873 | Common Stock | |
| SpringWorks Therapeutics Inc | Saqib Islam | Director, Chief Executive Officer | 19 Jul 2021 | 43,928 | 840,124 (1%) | 0% | 76.1 | 3,342,438 | Common Stock | |
| SpringWorks Therapeutics Inc | Saqib Islam | Director, Chief Executive Officer | 19 Jul 2021 | 18,572 | 821,552 (1%) | 0% | 77.7 | 1,442,751 | Common Stock | |
| Passage Bio Inc | Saqib Islam | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2021 | 16,918 | 16,918 | - | - | Director Stock Option (Right to Buy) | |
| SpringWorks Therapeutics Inc | Saqib Islam | Director, Chief Executive Officer | 19 Apr 2021 | 38,425 | 908,127 (2%) | 0% | 69.0 | 2,652,827 | Common Stock | |
| SpringWorks Therapeutics Inc | Saqib Islam | Director, Chief Executive Officer | 19 Apr 2021 | 24,075 | 884,052 (2%) | 0% | 66.4 | 1,598,279 | Common Stock | |
| SpringWorks Therapeutics Inc | Saqib Islam | Director, Chief Executive Officer | 19 Jan 2021 | 60,301 | 1,225,196 (2%) | 0% | 78.5 | 4,736,209 | Common Stock | |
| SpringWorks Therapeutics Inc | Saqib Islam | Director, Chief Executive Officer | 19 Jan 2021 | 2,199 | 1,222,997 (2%) | 0% | 78.8 | 173,180 | Common Stock | |
| SpringWorks Therapeutics Inc | Saqib Islam | Director, Chief Executive Officer | 07 Jan 2021 | 300,000 | 300,000 | - | - | Stock Option (Right to Buy) | ||
| SpringWorks Therapeutics Inc | Saqib Islam | Director, Chief Executive Officer | 07 Jan 2021 | 37,500 | 1,285,497 (2%) | 0% | 0 | Common Stock |